SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-023139
Filing Date
2011-04-28
Accepted
2011-04-28 07:02:50
Documents
12
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a11-8826_110q.htm 10-Q 1148606
2 EX-12.1 a11-8826_1ex12d1.htm EX-12.1 71244
3 EX-31.1 a11-8826_1ex31d1.htm EX-31.1 12944
4 EX-31.2 a11-8826_1ex31d2.htm EX-31.2 12956
5 EX-32.1 a11-8826_1ex32d1.htm EX-32.1 7219
6 EX-32.2 a11-8826_1ex32d2.htm EX-32.2 7212
  Complete submission text file 0001104659-11-023139.txt   4943160

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT uthr-20110331.xml EX-101.INS 708424
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20110331.xsd EX-101.SCH 27733
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20110331_cal.xml EX-101.CAL 57794
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20110331_def.xml EX-101.DEF 110775
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20110331_lab.xml EX-101.LAB 363080
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20110331_pre.xml EX-101.PRE 161110
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 11785508
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1